You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
Colorcon
Express Scripts
AstraZeneca
McKinsey

Last Updated: May 8, 2021

DrugPatentWatch Database Preview

Meloxicam - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for meloxicam and what is the scope of patent protection?

Meloxicam is the generic ingredient in five branded drugs marketed by Lupin Ltd, Novitium Pharma, Zyla, Baudax, Avondale Pharms, Tersera, Anda Repository, Apotex Inc, Aurobindo Pharma, Cipla, Cr Double Crane, Dr Reddys Labs Inc, Glenmark Generics, Heritage Pharma, Impax Labs Inc, Lupin Pharms, Mylan, Nostrum Labs Inc, Puracap Pharm, Roxane, Strides Pharma, Sun Pharm Inds Inc, Taro, Unichem, Yabao Pharm, Yung Shin Pharm, Zydus Pharms Usa, and Boehringer Ingelheim, and is included in twenty-nine NDAs. There are ten patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Meloxicam has fifty-eight patent family members in twenty-three countries.

There are twenty-two drug master file entries for meloxicam. Thirty-nine suppliers are listed for this compound.

Drug Prices for meloxicam

See drug prices for meloxicam

Drug Sales Revenue Trends for meloxicam

See drug sales revenues for meloxicam

Recent Clinical Trials for meloxicam

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Emory UniversityPhase 4
Rothman Institute OrthopaedicsPhase 3
Daewoong Pharmaceutical Co. LTD.Phase 1

See all meloxicam clinical trials

Pharmacology for meloxicam
Paragraph IV (Patent) Challenges for MELOXICAM
Tradename Dosage Ingredient NDA Submissiondate
VIVLODEX CAPSULE;ORAL meloxicam 207233 2017-01-09
MOBIC SUSPENSION;ORAL meloxicam 021530 2009-12-17

US Patents and Regulatory Information for meloxicam

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla MELOXICAM meloxicam TABLET;ORAL 077929-002 Jul 19, 2006 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Yabao Pharm MELOXICAM meloxicam TABLET;ORAL 077933-001 Jul 19, 2006 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Sun Pharm Inds Inc MELOXICAM meloxicam TABLET;ORAL 077937-001 Jul 19, 2006 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Avondale Pharms MOBIC meloxicam SUSPENSION;ORAL 021530-001 Jun 1, 2004 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Lupin Pharms MELOXICAM meloxicam TABLET;ORAL 077944-001 Jul 19, 2006 AB RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Yabao Pharm MELOXICAM meloxicam TABLET;ORAL 077933-002 Jul 19, 2006 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for meloxicam

Country Patent Number Estimated Expiration
Mexico 2016016212   Get Started for $10
China 107073010   Get Started for $10
Japan 2020125345   Get Started for $10
World Intellectual Property Organization (WIPO) 2010138539   Get Started for $10
World Intellectual Property Organization (WIPO) 2015191595   Get Started for $10
Australia 2019231858   Get Started for $10
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Merck
Express Scripts
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.